MX2023006720A - Tratamiento con ciclobenzaprina para fibromialgia. - Google Patents
Tratamiento con ciclobenzaprina para fibromialgia.Info
- Publication number
- MX2023006720A MX2023006720A MX2023006720A MX2023006720A MX2023006720A MX 2023006720 A MX2023006720 A MX 2023006720A MX 2023006720 A MX2023006720 A MX 2023006720A MX 2023006720 A MX2023006720 A MX 2023006720A MX 2023006720 A MX2023006720 A MX 2023006720A
- Authority
- MX
- Mexico
- Prior art keywords
- fibromyalgia
- dosage units
- cyclobenzaprine
- cyclobenzaprine hcl
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physiology (AREA)
- Inorganic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063122469P | 2020-12-07 | 2020-12-07 | |
| PCT/US2021/062244 WO2022125572A1 (en) | 2020-12-07 | 2021-12-07 | Cyclobenzaprine treatment for fibromyalgia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023006720A true MX2023006720A (es) | 2023-08-18 |
Family
ID=79686930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023006720A MX2023006720A (es) | 2020-12-07 | 2021-12-07 | Tratamiento con ciclobenzaprina para fibromialgia. |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20240024256A1 (https=) |
| EP (1) | EP4255407A1 (https=) |
| JP (1) | JP2023554692A (https=) |
| CN (1) | CN116940340A (https=) |
| AU (1) | AU2021396509A1 (https=) |
| CA (1) | CA3204202A1 (https=) |
| IL (1) | IL303497A (https=) |
| MX (1) | MX2023006720A (https=) |
| WO (1) | WO2022125572A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3260042A1 (en) * | 2022-06-21 | 2023-12-28 | Tonix Pharmaceuticals Holding Corp. | CYCLOBENZAPRINE TREATMENT FOR POST-ACUTE SEQUELAE OF A (SARS)-COV-2 (PASC) INFECTION |
| WO2025137348A1 (en) * | 2023-12-19 | 2025-06-26 | Tonix Pharmaceuticals Holding Corp. | Cyclobenzaprine hcl for use in treating fibromyalgia with early onset response and favorable tolerability and side effect profile |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS63822B1 (sr) | 2012-06-15 | 2023-01-31 | Tonix Pharma Holdings Ltd | Kompozicije i postupci za transmukoznu apsorpciju |
| SMT202400324T1 (it) | 2013-03-15 | 2024-11-15 | Tonix Pharma Ltd | Formulazioni eutettiche di ciclobenzaprina cloridrato e mannitolo |
| MY186047A (en) * | 2014-09-18 | 2021-06-17 | Tonix Pharma Holdings Ltd | Eutectic formulations of cyclobenzaprine hydrochloride |
| US20220117915A1 (en) * | 2018-08-20 | 2022-04-21 | Tonix Pharma Holdings Limited | Methods of treating acute stress disorder and posttraumatic stress disorder |
-
2021
- 2021-12-07 US US18/265,525 patent/US20240024256A1/en active Pending
- 2021-12-07 EP EP21844438.8A patent/EP4255407A1/en active Pending
- 2021-12-07 IL IL303497A patent/IL303497A/en unknown
- 2021-12-07 MX MX2023006720A patent/MX2023006720A/es unknown
- 2021-12-07 JP JP2023542924A patent/JP2023554692A/ja active Pending
- 2021-12-07 AU AU2021396509A patent/AU2021396509A1/en active Pending
- 2021-12-07 CN CN202180089897.8A patent/CN116940340A/zh active Pending
- 2021-12-07 WO PCT/US2021/062244 patent/WO2022125572A1/en not_active Ceased
- 2021-12-07 CA CA3204202A patent/CA3204202A1/en active Pending
-
2025
- 2025-12-16 US US19/421,039 patent/US20260108477A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2021396509A1 (en) | 2023-06-29 |
| WO2022125572A1 (en) | 2022-06-16 |
| CN116940340A (zh) | 2023-10-24 |
| EP4255407A1 (en) | 2023-10-11 |
| US20240024256A1 (en) | 2024-01-25 |
| JP2023554692A (ja) | 2023-12-28 |
| CA3204202A1 (en) | 2022-06-16 |
| IL303497A (en) | 2023-08-01 |
| US20260108477A1 (en) | 2026-04-23 |
| AU2021396509A9 (en) | 2024-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Vuagnat et al. | Shoulder pain in hemiplegia revisited: contribution of functional electrical stimulation and other therapies | |
| MY201603A (en) | Combination of dextromethorphan and bupropion for treating depression | |
| MX2019013279A (es) | Metodos de tratamiento del sindrome de doose utilizando fenfluramina. | |
| CO2018006358A2 (es) | Tratamiento de la enfermedad de fabry en pacientes no tratados y tratados previamente con ert | |
| NZ767378A (en) | Dosage forms and methods for enantiomerically enriched or pure bupropion | |
| CY1107262T1 (el) | Θεραπεια της εξαρτησης στερησης | |
| MX2011007854A (es) | Metodos para tratar infartos agudos al miocardio y trastornos relacionados. | |
| MY199903A (en) | Combination therapy with controlled-release cnp agonists | |
| PE20142319A1 (es) | Tratamiento de esclerosis multiple con combinacion de laquinimod y acetato de glatiramero | |
| CL2023000296A1 (es) | Uso de dexpramipexol para el tratamiento del asma moderado a grave | |
| MX2023006720A (es) | Tratamiento con ciclobenzaprina para fibromialgia. | |
| AR114392A1 (es) | Tratamiento de pacientes con enfermedad de fabry clásica | |
| MX2025001920A (es) | Tratamiento de enfermedades y trastornos asociados a las mitocondrias, incluyendo los sintomas de los mismos usando pridopidina | |
| EA202090242A1 (ru) | Лечение болезни фабри у фзт-наивных и фзт-леченных пациентов | |
| Moghadam et al. | The effects of gabapentin on methadone based addiction treatment: a randomized controlled trial | |
| MX2023003258A (es) | Tratamiento de enfermedades mediadas por nf-kb. | |
| Blok et al. | Intravenous acetaminophen does not have an opioid sparing effect in Emergency Department patients with painful conditions | |
| MX2025000142A (es) | Tratamiento con ciclobenzaprina para las secuelas postagudas de la infección por (sars)-cov-2 (pasc) | |
| Massey | Reduction of fibromyalgia symptoms through intravenous nutrient therapy: results of a pilot clinical trial | |
| Kilic | Melatonin for chronic back pain (the MOCHA trial): A study protocol for a randomized, double blind, placebo-contolled trial | |
| MX2021007324A (es) | Terapia oral con acido 6,8-bis-benciltio-octanoico. | |
| SA522432821B1 (ar) | توليفة من ميرتازابين وتيزانيدين للاستخدام في اضطرابات الألم | |
| MX2024002602A (es) | Métodos para prevenir y tratar el dolor y síntomas asociados. | |
| MX2023003540A (es) | Mejora del bienestar fisico y mental de los pacientes con hipoparatiroidismo. | |
| Jensen et al. | Onset of treatment response to a once-daily gastroretentive formulation of gabapentin in patients with postherpetic neuralgia |